A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation

  • Pancham, Krishna (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/12/183/5/21